Lunai Bioworks Featured in International Business Times Amid Partnership Talks and Rising Deal Activity

jueves, 18 de diciembre de 2025, 9:03 am ET1 min de lectura
LNAI--

Lunai Bioworks, a biotech firm, was featured in International Business Times for its AI-powered drug discovery and biodefense capabilities. The company is engaged in talks with pharmaceutical companies on CNS programs, such as Parkinson's and Alzheimer's disease, amid rising deal activity. Lunai's Augusta platform integrates clinical data, proteomics, and phenotypic analysis to address diseases with unmet needs. The firm's market capitalization has reset from $350 million to under $30 million in 2025, and partnership discussions could lead to valuation re-rating.

Lunai Bioworks Featured in International Business Times Amid Partnership Talks and Rising Deal Activity

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios